A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome

Authors

Ekin Güney, University of California, San Francisco
Sonika Dahiya, Washington University School of Medicine in St. Louis
et al.

Journal

Blood Advances

Publication Date

5-24-2022

Volume

6

Issue

10

First Page

3189

Last Page

3193

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2021006018

Rights and Permissions

Güney E, Lucas CG, Qi Z, Yu J, Zhang R, Ohgami RS, Rubenstein JL, Boué DR, Schafernak K, Wertheim GB, Dahiya S, Giulino-Roth L, Attarbaschi A, Barth MJ, Kothari S, Abla O, Cohen AL, Mendez JS, Bollen A, Perry A, Tihan T, Pekmezci M, Solomon DA, Wen KW. A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome. Blood Adv. 2022 May 24;6(10):3189-3193. doi: 10.1182/bloodadvances.2021006018. © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved

Recommended Citation

Güney, Ekin; Dahiya, Sonika; and et al., "A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome." Blood Advances. 6, 10. 3189 - 3193. (2022).
https://digitalcommons.wustl.edu/oa_4/1376

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.